FDA Classifies Recall of Cardinal Health Presource Kits with BD Alaris Infusion Sets as Class I
The U.S. Food and Drug Administration (FDA) has classified Cardinal Health's correction of certain Presource convenience kits as a Class I recall, the most serious recall category. On November 16, 2026, the agency updated its alert after initially issuing an early warning in October. The decision follows reports that these convenience kits contain recalled BD Alaris pump infusion sets. Malfunctioning sets can cause unpredictable pump behavior, including under-infusion, over-infusion, or complete failure to infuse. These issues can result in severe health complications, particularly for high-risk patients such as neonates, pediatric patients, and the critically ill. Rather than pulling entire kits from facilities, Cardinal Health asked customers in a September 24, 2026 letter to locate and quarantine affected packs. Staff must place visible warning labels on the kits directing clinicians to discard the recalled infusion sets before use. As of August 19, 2026, BD reported no serious injuries or deaths tied to the issue.
What was announced
The U.S. Food and Drug Administration updated a safety alert regarding Cardinal Health Presource convenience kits. On November 16, 2026, the FDA classified the action as a Class I recall, indicating that using affected devices without correction could cause severe injury or death.
The issue stems from component infusion sets made by BD and CareFusion 303, Inc. Cardinal Health included these recalled BD Alaris pump infusion sets inside certain Presource packs. These packaged kits gather instruments, dressings, and pharmaceuticals together for specific medical or surgical procedures.
Cardinal Health sent a letter to impacted customers on September 24, 2026. The company instructed health facilities to locate and quarantine affected kits. Instead of returning the full packs, staff must affix clear warning labels to the front of each kit, telling clinicians to remove and discard the recalled infusion sets before using the rest of the pack.
What it means
Infusion pumps deliver fluids, medications, and nutrients to patients. When an infusion set malfunctions, the pump may deliver too much liquid, too little liquid, or fail to deliver anything at all.
Such errors present serious risks, especially for vulnerable patient groups like newborns, children, and intensive care patients. Cardinal Health noted that the outcome depends on individual patient factors and the specific medication being given.
Healthcare facilities using Presource kits must follow the labeling instructions carefully. Distributors who resold the kits must pass the warning along to their customers. Patients or staff experiencing quality problems or adverse events can report them to the FDA MedWatch program or call Cardinal Health Quality Systems directly at (800) 292-9332.
What the announcement does not tell us
Several background details remain unstated in the announcement. The FDA document does not state how many total Presource kits or infusion sets contain the defect. It also does not list the specific catalog or lot numbers for affected kits directly in the alert text.
The announcement does not detail how the malfunction happens inside the pump sets. Additionally, while BD reported no serious injuries or deaths associated with the issue as of August 19, 2026, the update does not state whether any injury reports arrived after that date.
How this was written
This analysis was written with AI from the official announcement below, using only facts that announcement states. The quoted wording is FDA MedWatch Safety Alerts’s own. Always check the original before acting on anything here.
Cardinal Health Presource Kits containing recalled BD Alaris Pump Infusion Sets should be corrected prior to continued use
Opens www.fda.gov
More from FDA MedWatch Safety Alerts
- Early Alert: Heraeus Medical Components Removes Vascular Guidewires20 November 2026
- Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level Recall of One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, Due to Potential Metal Contamination20 November 2026
- Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Sterile Products Due to Lack of Sterility Assurance20 November 2026
- Early Alert: Outset Medical Updates Use Instructions for the Tablo Console and the TabloCart with Prefiltration Drawer19 November 2026
- Medical Device Correction Update Luna® G3 BPAP System (Model LG3800-30VT)19 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.